nodes	percent_of_prediction	percent_of_DWPC	metapath
Zidovudine—CYP2A6—Methimazole—Graves' disease	0.367	0.511	CbGbCtD
Zidovudine—CYP2C19—Methimazole—Graves' disease	0.152	0.211	CbGbCtD
Zidovudine—CYP2C9—Methimazole—Graves' disease	0.126	0.176	CbGbCtD
Zidovudine—CYP3A4—Methimazole—Graves' disease	0.0734	0.102	CbGbCtD
Zidovudine—Pigmentation skin—Methimazole—Graves' disease	0.0383	0.147	CcSEcCtD
Zidovudine—Pigmentation skin—Propylthiouracil—Graves' disease	0.0325	0.125	CcSEcCtD
Zidovudine—Splenomegaly—Propylthiouracil—Graves' disease	0.0214	0.0822	CcSEcCtD
Zidovudine—Pigmentation disorder—Methimazole—Graves' disease	0.0209	0.0804	CcSEcCtD
Zidovudine—Pigmentation disorder—Propylthiouracil—Graves' disease	0.0178	0.0684	CcSEcCtD
Zidovudine—Aplastic anaemia—Methimazole—Graves' disease	0.00656	0.0252	CcSEcCtD
Zidovudine—Vasculitis—Propylthiouracil—Graves' disease	0.00609	0.0234	CcSEcCtD
Zidovudine—Lymphadenopathy—Methimazole—Graves' disease	0.00595	0.0228	CcSEcCtD
Zidovudine—Aplastic anaemia—Propylthiouracil—Graves' disease	0.00558	0.0214	CcSEcCtD
Zidovudine—Lymphadenopathy—Propylthiouracil—Graves' disease	0.00506	0.0194	CcSEcCtD
Zidovudine—TERT—connective tissue—Graves' disease	0.00431	0.207	CbGeAlD
Zidovudine—Neuropathy peripheral—Methimazole—Graves' disease	0.00383	0.0147	CcSEcCtD
Zidovudine—Jaundice—Methimazole—Graves' disease	0.00381	0.0146	CcSEcCtD
Zidovudine—Agranulocytosis—Methimazole—Graves' disease	0.00365	0.014	CcSEcCtD
Zidovudine—Hepatitis—Methimazole—Graves' disease	0.00351	0.0135	CcSEcCtD
Zidovudine—Neuropathy peripheral—Propylthiouracil—Graves' disease	0.00326	0.0125	CcSEcCtD
Zidovudine—Jaundice—Propylthiouracil—Graves' disease	0.00324	0.0124	CcSEcCtD
Zidovudine—Agranulocytosis—Propylthiouracil—Graves' disease	0.0031	0.0119	CcSEcCtD
Zidovudine—Hepatitis—Propylthiouracil—Graves' disease	0.00298	0.0115	CcSEcCtD
Zidovudine—Vertigo—Methimazole—Graves' disease	0.00275	0.0105	CcSEcCtD
Zidovudine—Leukopenia—Methimazole—Graves' disease	0.00274	0.0105	CcSEcCtD
Zidovudine—Myalgia—Methimazole—Graves' disease	0.0026	0.00999	CcSEcCtD
Zidovudine—Arthralgia—Methimazole—Graves' disease	0.0026	0.00999	CcSEcCtD
Zidovudine—Dysgeusia—Propylthiouracil—Graves' disease	0.00254	0.00977	CcSEcCtD
Zidovudine—Oedema—Methimazole—Graves' disease	0.00249	0.00958	CcSEcCtD
Zidovudine—Thrombocytopenia—Methimazole—Graves' disease	0.00244	0.00938	CcSEcCtD
Zidovudine—Vertigo—Propylthiouracil—Graves' disease	0.00233	0.00896	CcSEcCtD
Zidovudine—Leukopenia—Propylthiouracil—Graves' disease	0.00233	0.00893	CcSEcCtD
Zidovudine—TK1—adipose tissue—Graves' disease	0.00228	0.109	CbGeAlD
Zidovudine—Musculoskeletal discomfort—Methimazole—Graves' disease	0.00227	0.00872	CcSEcCtD
Zidovudine—Paraesthesia—Methimazole—Graves' disease	0.00224	0.0086	CcSEcCtD
Zidovudine—Somnolence—Methimazole—Graves' disease	0.00222	0.00851	CcSEcCtD
Zidovudine—Arthralgia—Propylthiouracil—Graves' disease	0.00221	0.00849	CcSEcCtD
Zidovudine—Myalgia—Propylthiouracil—Graves' disease	0.00221	0.00849	CcSEcCtD
Zidovudine—Dyspepsia—Methimazole—Graves' disease	0.0022	0.00843	CcSEcCtD
Zidovudine—Oedema—Propylthiouracil—Graves' disease	0.00212	0.00814	CcSEcCtD
Zidovudine—Thrombocytopenia—Propylthiouracil—Graves' disease	0.00208	0.00797	CcSEcCtD
Zidovudine—Urticaria—Methimazole—Graves' disease	0.00198	0.00761	CcSEcCtD
Zidovudine—Body temperature increased—Methimazole—Graves' disease	0.00197	0.00757	CcSEcCtD
Zidovudine—TK1—thyroid gland—Graves' disease	0.00197	0.0947	CbGeAlD
Zidovudine—Musculoskeletal discomfort—Propylthiouracil—Graves' disease	0.00193	0.00742	CcSEcCtD
Zidovudine—Paraesthesia—Propylthiouracil—Graves' disease	0.0019	0.00731	CcSEcCtD
Zidovudine—Somnolence—Propylthiouracil—Graves' disease	0.00189	0.00724	CcSEcCtD
Zidovudine—SLC29A2—adipose tissue—Graves' disease	0.00188	0.0905	CbGeAlD
Zidovudine—Dyspepsia—Propylthiouracil—Graves' disease	0.00187	0.00717	CcSEcCtD
Zidovudine—Pruritus—Methimazole—Graves' disease	0.00176	0.00677	CcSEcCtD
Zidovudine—Urticaria—Propylthiouracil—Graves' disease	0.00168	0.00647	CcSEcCtD
Zidovudine—Body temperature increased—Propylthiouracil—Graves' disease	0.00168	0.00644	CcSEcCtD
Zidovudine—SLC29A2—thyroid gland—Graves' disease	0.00163	0.0783	CbGeAlD
Zidovudine—Vomiting—Methimazole—Graves' disease	0.00159	0.00609	CcSEcCtD
Zidovudine—Rash—Methimazole—Graves' disease	0.00157	0.00604	CcSEcCtD
Zidovudine—Dermatitis—Methimazole—Graves' disease	0.00157	0.00603	CcSEcCtD
Zidovudine—Headache—Methimazole—Graves' disease	0.00156	0.006	CcSEcCtD
Zidovudine—Pruritus—Propylthiouracil—Graves' disease	0.0015	0.00576	CcSEcCtD
Zidovudine—Nausea—Methimazole—Graves' disease	0.00148	0.00569	CcSEcCtD
Zidovudine—Vomiting—Propylthiouracil—Graves' disease	0.00135	0.00518	CcSEcCtD
Zidovudine—Rash—Propylthiouracil—Graves' disease	0.00134	0.00513	CcSEcCtD
Zidovudine—Dermatitis—Propylthiouracil—Graves' disease	0.00134	0.00513	CcSEcCtD
Zidovudine—Headache—Propylthiouracil—Graves' disease	0.00133	0.0051	CcSEcCtD
Zidovudine—Nausea—Propylthiouracil—Graves' disease	0.00126	0.00484	CcSEcCtD
Zidovudine—ABCC5—pituitary gland—Graves' disease	0.00102	0.0491	CbGeAlD
Zidovudine—ABCC5—adipose tissue—Graves' disease	0.00102	0.0489	CbGeAlD
Zidovudine—SLC22A8—eye—Graves' disease	0.000946	0.0455	CbGeAlD
Zidovudine—CYP2A6—adipose tissue—Graves' disease	0.000911	0.0438	CbGeAlD
Zidovudine—ABCC5—thyroid gland—Graves' disease	0.00088	0.0423	CbGeAlD
Zidovudine—ABCC4—adipose tissue—Graves' disease	0.000705	0.0339	CbGeAlD
Zidovudine—ABCC4—thyroid gland—Graves' disease	0.00061	0.0293	CbGeAlD
Zidovudine—CYP2C8—pituitary gland—Graves' disease	0.000514	0.0247	CbGeAlD
Zidovudine—ABCG2—pituitary gland—Graves' disease	0.0005	0.024	CbGeAlD
Zidovudine—ABCG2—adipose tissue—Graves' disease	0.000497	0.0239	CbGeAlD
Zidovudine—ABCG2—thyroid gland—Graves' disease	0.000431	0.0207	CbGeAlD
Zidovudine—ABCB1—pituitary gland—Graves' disease	0.000246	0.0118	CbGeAlD
Zidovudine—ABCB1—adipose tissue—Graves' disease	0.000245	0.0118	CbGeAlD
Zidovudine—ABCB1—thyroid gland—Graves' disease	0.000212	0.0102	CbGeAlD
